AstraZeneca
oncology highlights demonstrates harnessing of in house capabilities to build early stage pipeline first clinical data for car therapy preclinical data for three in house developed first disclosure and preclinical data for molecule targeting i | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
April 2023
Slide
17 of 41
Related slides by other companies
Ocuphire Pharma
Results
October 2022
preclinical data oral blocks | Ocuphire Pharma
Immix Biopharma
Investor Presentation
March 2024
preclinical data provides translational rationale combination rationale | Immix Biopharma
BioNTech
Results
March 2021
multiple oncology trials with registrational potential starting in | BioNTech
BioNTech
Results
May 2021
multiple oncology trials with registrational potential starting in plan to start randomized phase trials for programs advanced oncology pipeline programs near term milestones | BioNTech
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights